Table 3.
In-hospital Outcomes
| Variables | Medical Management (n = 5) | Delayed Surgery + Medical Management (n = 24) | Surgery (n = 47) |
|---|---|---|---|
| Postoperative COVID-19 testing | N/A | N/A | 8 (17.0) |
| Positive COVID-19 | N/A | N/A | 1 (12.5) |
| In-hospital mortality | 1 (20.0) | 1 (4.2) | 3 (6.4) |
| Cause of death | |||
| Respiratory failure related to COVID-19 | 0 | 0 | 1 (33.3) |
| Neurological | 0 | 0 | 2 (66.7) |
| Aortic rupture | 1 (20.0) | 1 (4.2) | 0 |
| Disabling stroke | 0 | 0 | 3 (6.4) |
| Spinal cord injury | 0 | 0 | 2 (4.3) |
| Tracheostomy | 0 | 2 (8.0) | 3 (10.0) |
| Reintubation | 1 (4.2) | 2 (8.0) | 2 (4.3) |
| Pneumonia | 0 | 6 (24.0) | 10 (21.3) |
| Prolonged mechanical ventilation | 1 (20.0) | 5 (20.0) | 14 (29.8) |
| Nitric oxide | 0 | 0 | 2 (4.3) |
| Mechanical ventilation duration (h) | N/A | N/A | 41 (18.5–66.2) |
| Renal failure | 1 (20.0) | 3 (12.5) | 7 (14.9) |
| Dialysis* | 0 | 1 (4.2) | 3 (6.4) |
| ICU length of stay (h) | N/A | N/A | 112 (68–165) |
| Postoperative length of stay (d) | N/A | N/A | 16 (11.6–22.0) |
⁎
Among patients without end-stage renal disease on dialysis; COVID-19, coronavirus disease 2019; N/A, not applicable.